Showing results (121-130 of 281) with videos related to
Sort By:
Pageof 29
The New England Journal of Medicine|January 20, 2000
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients, S Yusuf, P Sleight, et al.BMJ (Clinical Research Ed.)|December 14, 1991
Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trialsK K Teo, S Yusuf, R Collins, et al.Journal of Preventive Medicine and Hygiene|July 18, 2019
Practice of safety measures among inter-city commercial vehicle drivers in Kwara State, NigeriaA G Salaudeen, K A Durowade, A S Yusuf, et al.The American Journal of Cardiology|February 1, 1987
Significance of elevated MB isoenzyme with normal creatine kinase in acute myocardial infarctionS Yusuf, R Collins, L Lin, et al.Heart (British Cardiac Society)|August 1, 1996
Double blind placebo controlled trial of short term transdermal scopolamine on heart rate variability in patients with chronic heart failureG Venkatesh, E L Fallen, M V Kamath, et al.Annals of Internal Medicine|April 17, 2001
Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trialJ F Mann, H C Gerstein, J Pogue, et al.Acta Medica Scandinavica|May 1, 1982
Factors of importance for QRS complex recovery after acute myocardial infarctionS Yusuf, E Estrada-Yamamoto, C P Reyes, et al.The Nigerian Postgraduate Medical Journal|May 11, 2013
Knowledge of Glasgow coma scale by physicians in a tertiary health institution in NigeriaA S Yusuf, A G Salaudeen, A A Adewale, et al.Ethnicity & Health|April 4, 1998
Classifying ethnicity utilizing the Canadian Mortality Data BaseT Sheth, M Nargundkar, K Chagani, et al.Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|August 23, 2005
The HOPE (Heart Outcomes Prevention Evaluation) Study and its consequencesM J McQueen, E Lonn, H C Gerstein, et al.Pageof 29